FindTrial
Sign In

Comparison of three drug groups effectiveness, intravenous Lidocaine and Dexamethasone, intravenous Ketamine and Dexamethasone and Dexamethasone alone in the managment of respiratory complications after tonsillectomy.

Comparison of three drug groups effectiveness, intravenous Lidocaine and Dexamethasone, intravenous Ketamine and Dexamethasone and Dexamethasone alone in the managment of respiratory complications after tonsillectomy.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210718051928N1
Enrollment
100
Registered
2021-09-06
Start date
2021-09-01
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory complications after tonsillectomy. Acute laryngotracheitis

Interventions

Intervention 1: Intervention group1: Dexamethasone 0.1 mg / kg and Lidocaine 1 mg / kg in a 5cc syring with the same volume witch is injected as a single dose before extubation. Intervention 2: Inter

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: All ASA1 patients are candidates for elective tonsillectomy Age between 2-18 years Parental consent

Exclusion criteria

Exclusion criteria: Active upper respiratory tract infection during the two weeks prior to surgery Active lower respiratory tract infection during the 5 weeks prior to surgery History of asthma History of allergy to Lidocaine , Dexamethasone and Ketamine ASA2 patients and higher

Design outcomes

Primary

MeasureTime frame
The percentage of people whose airway irritability score is 8-10. Timepoint: Every ten minutes after entering the recovery and the moment of leaving the recovery. Method of measurement: Use of airway irritability questionnaire.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomayye Hoghughi

Esfahan University of Medical Sciences

yameisam@yahoo.com+98 31 3240 3303

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026